Skip to content
Company Analysis

Guardant Health, Inc. GH

A comprehensive view of key metrics, scores, and financial health for Guardant Health, Inc.

Overview of Guardant Health, Inc.

GH NMS
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Large Cap
Guardant Health, Inc. (GH), is a Large Cap company, in the Diagnostics & Research industry, last closed at $131.62, about 95.5% overvalued vs fair value, +167.0% 1Y return, ranked 936/1122 in sector.
Metrics Rev Growth 32.9% ROE 348.4% Gross Margin 64.5%
USD 131.62
0.55%
(Delayed)
• Vol 90d: 59.4%
52-Week Range
Market Cap
$17.36B
Enterprise Value
$18.07B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Weak
Valuation
Weak
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Weak
Valuation
Weak
Completeness: 82%
Confidence: 53%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://guardanthealth.com
HQ Palo Alto, CA
Employees 2,490
Fiscal year Dec 31

Next Events

Earnings Jul 29 Estimated

Fair Value Snapshot

Bear Base Bull
$5
$6
$7
Current: $131.62 -96% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$982.0M
32.9%%
Gross Profit
$633.0M
40.9%%
Operating Income (GAAP)
$-437.2M
1.4%%
EBITDA
$-373.9M
4.2%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
64.5%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
1/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Guardant Health, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
58
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
64
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 88% Coverage
Trade-Off Triangle Visualization A ternary plot showing GH's balance between Growth (51.3%), Profitability (31.4%), and Safety (17.4%). Growth 51% Safety 17% Profitability 31%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

74th percentile vs peers
75
Key Signals
Rev Growth YoY 32.9% 86p Revenue CAGR 3Y 29.8% 83p EPS Growth YoY 17.0% 47p
Strengths
  • Rev Growth YoY in top 20% of peers (32.9%, 86th percentile)
  • Revenue CAGR 3Y in top 20% of peers (29.8%, 83th percentile)
  • Growth above peer median with strong metric coverage (75%)
  • Strong liquidity position vs peers
Risks

No significant risks identified for this axis.

Profitability

45th percentile vs peers
46
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

25th percentile vs peers
25
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Guardant Health, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$5.91
- - -
-95.5% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000